JPS5820194A - Preparation of l-glutamic acid by fermentation method - Google Patents
Preparation of l-glutamic acid by fermentation methodInfo
- Publication number
- JPS5820194A JPS5820194A JP11893081A JP11893081A JPS5820194A JP S5820194 A JPS5820194 A JP S5820194A JP 11893081 A JP11893081 A JP 11893081A JP 11893081 A JP11893081 A JP 11893081A JP S5820194 A JPS5820194 A JP S5820194A
- Authority
- JP
- Japan
- Prior art keywords
- glutamic acid
- culture medium
- galactose
- escherichia
- liquid culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
この発明は発酵法によるL−グルタミン酸の製造法に関
する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing L-glutamic acid by fermentation.
L−グルタミン酸は、ブレビバクテリウム属、コリネバ
クテリウム属のフリネホルム細菌を用イテクルコース、
シュクロース、酢酸等の炭素源より製造されている。し
かしながらこれ゛らの従来用いられている≧リネホルム
細菌は、ガラクトース及びラクトースのいずれも資化す
ることができなく、従って、これらの糖類な含有する乳
ホエイ等の安価な原料を使用してL−グルタミン酸を製
造することはできなかった。L-glutamic acid is produced using Phrineform bacteria of the genus Brevibacterium and Corynebacterium.
It is manufactured from carbon sources such as sucrose and acetic acid. However, these conventionally used lineform bacteria cannot assimilate either galactose or lactose, and therefore L- It was not possible to produce glutamic acid.
叙上のような従来のL−グルタミン酸の製造法tこ対し
、本発明者らは、エシェリヒア属の微生物よりガラクト
ース又はラクトースを炭素源として高い収率でL−グル
タミン酸を製造する能力を有する菌株を分離することに
成功し、本発明を完成するに至った。In contrast to the conventional method for producing L-glutamic acid as described above, the present inventors developed a strain of Escherichia microorganisms that has the ability to produce L-glutamic acid in high yield using galactose or lactose as a carbon source. We succeeded in separating them and completed the present invention.
本発明において使用されるエシェリヒア属のL−グルタ
ミン酸生産能を有する微生物としては、具体的tこは、
エシェリヒア・コリAJ11499(FERM−P53
01、NRRLB−12286)、エシェリヒア・コリ
A J 11545 (FERM−P5407、NRR
LB−122(+9)曹AJ11499及びAJ115
45は以下のようにして育種分離されたものである。Specific examples of the microorganisms of the genus Escherichia having the ability to produce L-glutamic acid used in the present invention include Escherichia coli AJ11499 (FERM-P53
01, NRRLB-12286), Escherichia coli A J 11545 (FERM-P5407, NRR
LB-122 (+9) Cao AJ11499 and AJ115
No. 45 was bred and isolated as follows.
(1) エシェリヒア・コリEG −19株(K −1
2(ATCC10798)より誘導したAEC耐性株。(1) Escherichia coli EG-19 strain (K-1
2 (ATCC10798).
)を1eのし培地(ペプトン1%、酵母エキス0.5
%、グル* −ス0.1 %、NaCl 0.5%
; PT(7,21コ調整)中37cで約3時間振盪培
養を行い、対数増殖期に菌体を集菌後、フェノール法t
こよる通常のDNA抽出法によって染色体DNAを抽出
精製し、最終3.4mgを得た。) in 1e medium (peptone 1%, yeast extract 0.5
%, Glucose 0.1%, NaCl 0.5%
; After culturing with shaking at 37c in PT (7, 21 co-adjusted) for about 3 hours, collect the bacterial cells in the logarithmic growth phase, and then use the phenol method.
Chromosomal DNA was extracted and purified using a conventional DNA extraction method, and a final amount of 3.4 mg was obtained.
(2) ベクターとしてプラスミドpBR322のD
NAを次のようにして調製した。まず、pBR322を
プラスミドとして保有するエシェリヒア拳コリに一12
株の1種を1gのグルコース・カサミノ酸・無機塩培地
(グルコース2 t1NH4C11f、 NagHPO
46f、KHIPo。(2) D of plasmid pBR322 as a vector
NA was prepared as follows. First, we infected Escherichia fistula carrying pBR322 as a plasmid.
One strain was added to 1 g of glucose-casamino acid-mineral salt medium (glucose 2 t1NH4C11f, NagHPO
46f, KHIPo.
32、NaC1591MgSO4e7HqOO,1f。32, NaC1591MgSO4e7HqOO, 1f.
CaCIg−2T(20o、o 15 f、 カザミノ
酸2゜tを1eの純水に溶解後pH7,2に調整し゛た
ものを基本培地として用い、これtこサイアミン塩酸塩
100μ2を添加)に接種し、37cで対数後期まで培
養したのち170 pf /yxlのクロラムフェニコ
ールを添加し、さらに−夜培養した。CaCIg-2T (20°C, 15°F, casamino acid 2°T dissolved in 1E pure water and adjusted to pH 7.2 was used as the basic medium, to which was added 100μ2 of thiamine hydrochloride) was inoculated. , 37c until late logarithmic phase, 170 pf/yxl of chloramphenicol was added, and the cells were further cultured overnight.
この操作により、細胞内tこプラスミドDNAカ多z
tこ生産される。クロラムフェニコール添加後16時間
目に集菌し、リゾチーム・SDS処理によって溶菌させ
、3o、oooxr、1時間の超遠心により上清を得た
。これよりプラスミドDNAを濃縮後、セシウムクロラ
イド−エチジウムブロマイド平衡密度勾配遠心法tこよ
って最終480μmのpBR322° プラスミドDN
Aを分画採取した。This operation increases the amount of plasmid DNA in the cell.
t is produced. Bacteria were collected 16 hours after addition of chloramphenicol, lysed by lysozyme/SDS treatment, and supernatant obtained by ultracentrifugation at 3o, oooxr, for 1 hour. After concentrating the plasmid DNA from this, cesium chloride-ethidium bromide equilibrium density gradient centrifugation was performed to obtain a final 480 μm pBR322° plasmid DNA.
A fraction was collected.
+31 (11テ得た染色体DNA 10 pfをと
り、制限エンドヌクレアーゼ、Hlnd [7を与え3
7cで5分、10分、20分、30分又は60分反応さ
せ、部分的に又は完全tこ切断せしめた。+31 (Take 10 pf of the obtained chromosomal DNA and treat it with restriction endonuclease, Hlnd [7 and give 3
7C for 5, 10, 20, 30, or 60 minutes to allow partial or complete cleavage.
65tZ’、5分の熱処理後、T(ind[lで完全に
切断したpBR322と混合し、ATP及びジチオスレ
イトール存在下、T4ファージ由来のDNAリガーゼに
よってIOC,24時間DNAMの連結反応を行った。After heat treatment at 65tZ' for 5 minutes, it was mixed with pBR322 that had been completely digested with T(ind[l), and DNA ligation was performed using DNA ligase derived from T4 phage in the presence of ATP and dithiothreitol for 24 hours using IOC. .
65C,5分の熱処理後、反応液ケこ2倍容のエタノー
ルを加えて連結反応終了後のDNAを沈澱採取した。After heat treatment at 65C for 5 minutes, twice the volume of ethanol was added to the reaction solution to precipitate and collect the DNA after the completion of the ligation reaction.
(4) エシェリヒア・コリに一12株からニトロソ
グアニジン変異処理によって誘導したヒスチジン要求性
株El(R−13及びp−フルオロフェニルアラニン耐
性株Jf6283−5を、それぞれれを氷冷下0.I
M MgCl、、O−I M C* CIt各溶液tこ
順次懸濁させることによっていわゆるコンピテントな細
胞を調製した。このコンピテント細胞懸濁液に、(3)
で得たDNAの溶解液を加えて水冷下30分反応させ、
直ちz42C,2分のヒートショックを与えた後、再び
水冷下に30・分装置してDNAを細胞内に取り込ませ
た。つぎtここの細胞懸濁液の一定量を新たなL培地に
接種し、37C,2時間振盪培養を行って形質転換反応
を完了させた後、集菌洗滌し、再懸濁液を最少培地プレ
ート(グルコース291(NH4)、SO41f、に、
T(PO47f、I K)I2PO422、MgSO4
・7H,OO,1?、クエン酸ナトリウA0.5F、及
びAEC−T(CI O,5fを1eの純水に溶解し
pH7,2に調整したものに、寒天209を加えて殺菌
した固形培地に、アンピシリンを20μf/meとなる
よう加えたプレー鮨抹し、37Cで3日間培養した。(4) Histidine auxotrophic strain El (R-13) and p-fluorophenylalanine resistant strain Jf6283-5, which were induced from Escherichia coli by nitrosoguanidine mutation treatment, were each incubated at 0.1 ml under ice cooling.
So-called competent cells were prepared by sequentially suspending each solution of M MgCl, O-I M C* CIt. To this competent cell suspension, (3)
Add the DNA solution obtained in step 1 and react for 30 minutes under water cooling.
Immediately, the cells were subjected to a heat shock of z42C for 2 minutes, and then cooled with water again for 30 minutes to incorporate the DNA into the cells. Next, a certain amount of the cell suspension was inoculated into a new L medium, and cultured with shaking at 37C for 2 hours to complete the transformation reaction. plate (glucose 291 (NH4), SO41f,
T(PO47f, IK)I2PO422, MgSO4
・7H,OO,1? , sodium citrate A0.5F, and AEC-T (CIO, 5f were dissolved in 1e pure water and adjusted to pH 7.2, and agar 209 was added to sterilize the solid medium. Ampicillin was added at 20 μf/me. The plated sushi was added so that
生じたコロニーを釣菌し、その性質を調べたところ何れ
もAEC耐性、アンピシリン耐性を示した。そこで、こ
れらの菌株を形質転換株とした。When the resulting colonies were picked and their properties examined, they all showed AEC resistance and ampicillin resistance. Therefore, these strains were used as transformed strains.
このようにして、ERR−13を受容菌としてAJ11
499を、A283−5を受容菌と ・してAJ11
545をそれぞれ得た。In this way, ERR-13 was used as a recipient strain for AJ11.
499 and A283-5 as the recipient strain AJ11
545 were obtained respectively.
このようなエシェリヒア属のし一グルタミン酸生産能を
有する微生物を培養する際に使用される培地は、ラクト
ース又はガラクトースを炭素源として含有する以外は、
特にかわったものではない。ラクトース及びガラクトー
スとして、これらを含有する乳ホエイ、大豆ホエイ等を
使用してもよい。これらの炭素源のほかに、副炭素源と
してグルコース、シュクロース等が培地に含まれている
こともある。炭素源のほかにはアンモニウムイオン、ア
ンモニアガス、アンモニア水等の通常の窒素源、リン酸
イオン、マグネシウムイオン、カリイオン等の無機イオ
ン、更1こ必要會こよりビタミン、アミノ酸等の有機微
量栄養素が培地中に含まれる。The medium used for culturing such a microorganism of the genus Escherichia that has the ability to produce monoglutamic acid does not contain lactose or galactose as a carbon source.
It's nothing special. As lactose and galactose, milk whey, soybean whey, etc. containing these may be used. In addition to these carbon sources, the medium may also contain glucose, sucrose, etc. as auxiliary carbon sources. In addition to carbon sources, the culture medium contains ordinary nitrogen sources such as ammonium ions, ammonia gas, and aqueous ammonia, inorganic ions such as phosphate ions, magnesium ions, and potassium ions, and organic trace nutrients such as vitamins and amino acids. contained within.
培養は好気的条件下で行われる。培養の間、培養温度は
27ないし37rの範囲内の適当な温度會こ、培地のp
Hは、5.5から7.5の範囲の適当なpi(に、それ
ぞれ保つのが望ましい。かくして、1ないし4日間も培
養を続ければ培地中に著量のL−グルタミン酸が生成蓄
積される。Cultivation is carried out under aerobic conditions. During the culture, the culture temperature should be maintained at an appropriate temperature within the range of 27 to 37R, and the pH of the medium should be adjusted.
It is desirable to maintain H at an appropriate pi (in the range of 5.5 to 7.5).Thus, if the culture is continued for 1 to 4 days, a significant amount of L-glutamic acid will be produced and accumulated in the medium. .
培地中tこ蓄積されたL−グルタミン酸を採取する會こ
は、通常の方法で行うことができる。Collection of L-glutamic acid accumulated in the medium can be carried out by a conventional method.
実施例1
ガラクトース3.6tt/dl、(NH,)、So、
2.51/117!、KH,PO40,2y /dt
、MgSO4・7H,OO,1t/di、酵母エキスo
、o s t /dl、 L−チロシン10.0 mg
/ d11チアミン塩酸塩100μt / dt 5
FeSO,−71(,01vr9/di及びMn804
畳4H2011tg/dlを含み、pH7,or−調節
した培地を500耐フラスコに2Oyglずつ入れ殺菌
した。これに第1表に示す菌株を1白金耳植えつけ、3
1Cで48時間培養した。なお、培養途中、4597d
iの尿素水を0.3dずつ添加し、pHの低下を防止し
た。培養終了時tこおけるし一グルタミン酸の蓄積量は
第1表に示すとおりであった。Example 1 Galactose 3.6tt/dl, (NH,), So,
2.51/117! ,KH,PO40,2y/dt
, MgSO4・7H, OO, 1t/di, yeast extract o
, o s t /dl, L-tyrosine 10.0 mg
/ d11 thiamine hydrochloride 100 μt / dt 5
FeSO, -71 (,01vr9/di and Mn804
A medium containing tatami 4H2011 tg/dl and adjusted to pH 7 was placed in a 500-proof flask at 2 Oygl and sterilized. One platinum loop of the bacterial strains shown in Table 1 was planted on this, and 3
Cultured at 1C for 48 hours. In addition, during cultivation, 4597d
0.3 d of urea water was added at a time to prevent the pH from decreasing. At the end of the culture, the amount of monoglutamic acid accumulated in the tube was as shown in Table 1.
第 1 表
l6283−5 828
AJ11545 1109
EG−19720
AJ11499 1050
実施例2
乳糖597dl、(NH4)s 5o42.5 t /
ctt、K)L、 PO40,2f /di、MgS
O4−7)1,0 0.1t/di。1st Table l6283-5 828 AJ11545 1109
EG-19720 AJ11499 1050
Example 2 Lactose 597dl, (NH4)s 5o42.5t/
ctt, K) L, PO40, 2f/di, MgS
O4-7) 1,0 0.1t/di.
酵母エキスo、o s y /dl、 L−チロシン1
0.089 / dl 、チアミン塩酸塩100μf/
dt。Yeast extract o, o sy/dl, L-tyrosine 1
0.089/dl, thiamine hydrochloride 100μf/
dt.
FeSO4−7H,Olvrg/dl、Mn SO4・
4H1011g/ di、及び炭酸カルシウム2.5
t /lri (別殺菌添加)を含み、p)(7,0に
調節した培地を50011/フラスコ1こ20耐ずつ入
れ殺菌した。これに第2表に示す菌株を1白金耳植えつ
け、31Cで72時間培養した。培養終了時におけるし
一グルタミン酸の蓄積量は、第2表Vこ示す通りであっ
た。FeSO4-7H, Olvrg/dl, MnSO4・
4H1011g/di, and calcium carbonate 2.5
A culture medium adjusted to 7.0 and containing t/lri (separately added for sterilization) was sterilized by adding 50011/1 flask and sterilizing it. The cells were cultured for 72 hours.The amount of monoglutamic acid accumulated at the end of the culture was as shown in Table 2.
第 2 表
扁283−5 1050
AJ11545 1325
EC−19976
実施例3
下記の酸沈・乳ホエイな乳糖として5?/des(Nl
(4)、So、 2.5 f/dl、 KH,PO4
0,2f/dl。2nd Table 283-5 1050 AJ11545 1325 EC-19976 Example 3 5 as the following acid precipitated milk whey lactose? /des(Nl
(4), So, 2.5 f/dl, KH, PO4
0.2f/dl.
Mg5O,−7H,OO,1f/dl、酵母エキス0.
05t /de、、 L−チq シv 1o、o mg
/(H1チア = 7塩酸塩1o o ’p t /d
e、 Fe1on −7T(、o 11117/d/
!xMn 804−4Ht O1g17 / dl及び
炭酸カルシウム2.5t/dl(別殺、添加)を含み、
KO)IでpH7,2T1m調節した培地を調製し50
0ydフラスコ1こ20w5eずつ入れ、殺菌した。こ
れVこ第3表に示す菌株を1白金耳植えつけ、31Cで
72時間培養した。Mg5O, -7H, OO, 1f/dl, yeast extract 0.
05t/de,, L-Chiq Shiv 1o, o mg
/(H1thia = 7 hydrochloride 1o o 'pt /d
e, Fe1on-7T (, o 11117/d/
! Contains xMn 804-4Ht O1g17/dl and calcium carbonate 2.5t/dl (separately, added),
Prepare a medium adjusted to pH 7, 2T1m with KO)I and add 50
One 0yd flask was placed in each 20w5e flask and sterilized. One platinum loop of the bacterial strains shown in Table 3 was inoculated and cultured at 31C for 72 hours.
培養終了時におけるL−グルタミン酸の蓄mtは、第3
表tこ示す通りであった。The accumulated mt of L-glutamic acid at the end of the culture is
It was as shown in Table t.
酸沈・乳ホエイの成分は、水分93.9%、乳糖4.5
チ、全固形分6.1係、窒素化合物0.80チ、 −
灰分0.70チ、脂肪0.1チであった。The ingredients of acid-precipitated milk whey are 93.9% water and 4.5% lactose.
h, total solid content 6.1 parts, nitrogen compounds 0.80 parts, -
The ash content was 0.70 inch and the fat content was 0.1 inch.
第 3 表
A283−5 875AJ
11545 1055EC,−
19830
AJ11499 11 90
特許出願人 味の素株式会社Table 3 A283-5 875AJ
11545 1055EC, -
19830 AJ11499 11 90
Patent applicant Ajinomoto Co., Inc.
Claims (1)
物を、ラクトース又はガラクトースを炭素源として含有
する液体培地中に培養し、培地中に生成蓄積されたし一
グルタミン酸を採取することを特徴とする発酵法による
L−グルタミン酸の製造法。A fermentation method characterized in that a microorganism of the genus Escherichia capable of producing monoglutamic acid is cultured in a liquid medium containing lactose or galactose as a carbon source, and monoglutamic acid produced and accumulated in the medium is collected. Method for producing L-glutamic acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11893081A JPS5820194A (en) | 1981-07-29 | 1981-07-29 | Preparation of l-glutamic acid by fermentation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11893081A JPS5820194A (en) | 1981-07-29 | 1981-07-29 | Preparation of l-glutamic acid by fermentation method |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS5820194A true JPS5820194A (en) | 1983-02-05 |
Family
ID=14748724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11893081A Pending JPS5820194A (en) | 1981-07-29 | 1981-07-29 | Preparation of l-glutamic acid by fermentation method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5820194A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5573945A (en) * | 1994-01-10 | 1996-11-12 | Ajinomoto Co., Inc. | Mutant and method for producing L-glutamic acid by fermentation |
-
1981
- 1981-07-29 JP JP11893081A patent/JPS5820194A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5573945A (en) * | 1994-01-10 | 1996-11-12 | Ajinomoto Co., Inc. | Mutant and method for producing L-glutamic acid by fermentation |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0142676B2 (en) | ||
JPS58893A (en) | Preparation of l-isoleucine by fermentation | |
JPH04112795A (en) | Production of l-tryptophan by fermentation method | |
JP2817155B2 (en) | Production method of L-arginine by fermentation method | |
JPS61202694A (en) | Production of l-glutamine by fermentation method | |
JPS6115695A (en) | Preparation of l-isoleucine by fermentation method | |
JPS6115696A (en) | Preparation of l-isoleucine by fermentation method | |
JPS6274293A (en) | Production of l-isoleucine | |
JPS5931691A (en) | Preparation of l-threonine by fermentation | |
JPS5820194A (en) | Preparation of l-glutamic acid by fermentation method | |
JPS6368091A (en) | Production of amino acid | |
JPS62134083A (en) | Iron-containing microorganism and production thereof | |
JPS58175493A (en) | Preparation of guanosine by fermentation process | |
Fowden | Fluoroamino acids and protein synthesis | |
JPS63160592A (en) | Production method of L-valine | |
JPS6244171A (en) | Novel bacterium capable of producing l-glutamic acid | |
JPH0342070B2 (en) | ||
JPS62265988A (en) | Production of l-arginine by fermentation | |
JPH0378998B2 (en) | ||
JPS6224075B2 (en) | ||
JPS59192096A (en) | Preparation of l-tryptophan by fermentation | |
SU739104A1 (en) | Culture medium for p+virulence determinants | |
JPS5963194A (en) | Preparation of l-histidine by fermentation method | |
JPS60251893A (en) | Preparation of l-arginine by fermentation method | |
JPS5934894A (en) | Preparation of l-proline by fermentation |